Maravai LifeSciences

Life sciences company providing critical products to enable the development of drug therapies

Stránky společnosti

Ticker

MRVI.NASDAQ

Trh

Rok založení

2014

Uzávěrka

12/20/2020

Datum IPO

11/19/2020

Cena umístění

$27

Ziskovost

7.67%

O společnosti

Total Funding

$1B

Maravai LifeSciences was formed in March 2014 as a partnership among Carl Hull and Eric Tardif -- proven leaders in the life sciences industry -- and GTCR, a leading private equity firm. Maravai’s mission is to build a transformative life sciences products company by acquiring outstanding businesses and accelerating their growth. They do this through direct cash investments in their existing operations, by acquiring complementary businesses or product lines and by contributing our proven operating expertise.

Number of employees

51-100

Headquarters

San Diego, California, United States